Comment on curcumin attenuates acrylamide-lnduced cytotoxicity and genotoxicity in HepG2 cells by ROS scavenging

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 12, 2009, Pages 5644-5646

  Kurien, Biji T ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; CURCUMIN; MUTAGENIC AGENT; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; SCAVENGER;

CELL LINE; CHEMISTRY; CURCUMA LONGA; HUMAN; METABOLISM; NOTE;

ACRYLAMIDE; CELL LINE; CURCUMA; CURCUMIN; FREE RADICAL SCAVENGERS; HUMANS; MUTAGENS; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES;

EID: 67649233275     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf900846n     Document Type: Note

References (26)

1. Cao, J.; Liu, Y.; Jia, L.; Jiang, L. P.; Geng, C. Y.; Yao, X. F.; Kong, Y.; Jiang, B. N.; Zhong, L. F. Curcumin attenuates acrylamideinduced cytotoxicity and genotoxicity in HepG2 cells by ROS scavenging. J. Agric. Food Chem. 2008, 56, 12059-12063.
2. Friedman, M. Chemistry, biochemistry, and safety of acrylamide. A review. J. Agric. Food Chem. 2003, 51, 4504-4526.
3. Klaunig, J. E. Acrylamide carcinogenicity. J. Agric. Food Chem. 2008, 56, 5984-5988.
4. Aggarwal, B. B.; Kumar, A.; Aggarwal, M. S.; Shishodia, S. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons In Phytochemicals in Cancer Chemoprevention; Bagchi, D., Preuss, H.G., Eds.; CRC Press: Boca Raton, FL, 2004; pp 349-387.
5. Aggarwal, B. B.; Sundaram, C.; Malani, N.; Ichikawa, H. Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 2007, 595, 1-75.
6. Kurien, B. T.; Singh, A.; Matsumoto, H.; Scofield, R. H. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev. Technol. 2007, 5 (4), 567-576.
7. Rudrappa, T.; Bais, H. P. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J. Agrie. Food Chem. 2008, 56, 1955-1962.
8. Sharma, R. A.; McLelland, H. R.; Hill, K. A.; Ireson, C. R.; Euden, S. A.; Manson, M. M.; Pirmohamed, M.; Marnett, L. J.; Gescher, A. J.; Steward, W. P. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 2001, 7(7), 1894-1900.
9. Cheng, A. L.; Hsu, C. H.; Lin, J. K.; Hsu, M. M.; Ho, Y. F.; Shen, T. S.; Ko, J. Y.; Lin, J. T.; Lin, B. R.; Ming-Shiang, W.; Yu, H. S.; Jee, S. H.; Chen, G. S.; Chen, T. M.; Chen, C. A.; Lai, M. K.; Pu, Y. S.; Pan, M. H.; Wang, Y. J.; Tsai, C. C.; Hsieh, C. Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21, 2895-2900.
10. Lao, C. D.; Ruffin, M. T., 4th; Normolle, D.; Heath, D. D.; Murray, S. I.; Bailey, J. M.; Boggs, M. E.; Crowell, J.; Rock, C. L.; Brenner, D. E. Dose escalation of a curcuminoid formulation. BMC Complement Altern. Med. 2006, 6, 10-13.
11. Dhillon, N.; Aggarwal, B. B.; Newman, R. A.; Wolff, R. A.; Kunnumakkara, A. B.; Abbruzzese, J. L.; Ng, C. S.; Badmaev, V.; Kurzrock, R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008, 14 (14), 4491-4499.
12. Kurien, B. T.; Singh, A.; Matsumoto, H.; Scofield, R. H. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev. Technol. 2007, 5 (4), 567-576.
13. Kurien, B. T.; Scofield, R. H. Increasing the solubility of the nutraceutical curcumin by heat and inhibition of oxidative modification. Mol. Nutr. Food Res. 2009, 53 (2), 308.
14. Kurien, B. T.; Scofield, R. H. In vitro modification of solid phase multiple antigenic peptides/autoantigens with 4-hydroxy-2-nonenal (HNE) provide ideal substrates for detection of anti-HNE antibodies and peptide antioxidants. J. Immunol. Methods 2005, 303 (1-2), 66-75.
15. Kurien, B. T.; Scofield, R. H. Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification-an in vitro study. J. Ethnopharmacol 2007, 110 (2), 368-373.
16. Camici, G. G.; Steffel, J.; Akhmedov, A.; Schafer, N.; Baldinger, J.; Schulz, U.; Shojaati, K.; Matter, C. M.; Yang, Z.; Lüscher, T. F.; Tanner, F. C. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Circulation 2006, 114(14), 1512-1521.
17. Hanslick, J. L.; Lau, K.; Noguchi, K. K.; Olney, J. W.; Zorumski, C. F.; Mennerick, S.; Farber, N. B. Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system. Neurobiol Dis. 2008, Dec 3 [Epub ahead of print].
18. Nasrallah, F. A.; Garner, B.; Ball, G. E.; Rae, C. Modulation of brain metabolism by very low concentrations of the commonly used drug delivery vehicle dimethyl sulfoxide (DMSO). J. Neurosci. Res. 2008, 86 (1), 208-214.
19. Quitschke, W. W. Differential solubility of curcuminoids in serum and albumin solutions: implications for analytical and therapeutic applications. BMC Biotechnol. 2008, 5, 84.
20. Safavy, A.; Raisch, K. P.; Mantena, S.; Sanford, L. L.; Sham, S. W.; Krishna, N. R.; Bonner, J. A. Design and development of watersoluble curcumin conjugates as potential anticancer agents. J. Med. Chem. 2007, 50, 6284-6288.
21. Mathews, S. A.; Kurien, B. T.; Scofield R,H. Oral manifestations of Sjogren's syndrome (review). J. Dent. Res. 2008, 87 (4), 308-318.
22. Kurien, B. T.; Scofield, R. H. Autoantibody determination in the diagnosis of systemic lupus erythematosus (review). Scand. J. Immunol. 2006, 64 (3), 227-235.
23. Scofield, R. H.; Asfa, S.; Obeso, D.; Jonsson, R. Immunization with short peptides from the 60 kD Ro/SSA antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome. J. Immunol. 2005, 175 (12), 8409-8414.
24. Kurien, B. T.; Dsouza, A.; Scofield, R. H. Heat-solubilized curry spice curcumin inhibits antibody-antigen interaction in in vitro studies: a possible therapy to alleviate autoimmune disorders. Mol. Nutr. Food Res. Revisions 2009, submitted for publication.
25. Kurien, B. T.; Scofield, R. H. Heat mediated quick Coomassie blue protein staining and destaining of SDS-PAGE gels. Indian J. Biochem. Biophys. 1998, 35 (6), 385-389.
26. Kurien, B. T.; Scofield, R. H. Heat-solubilized curcumin should be considered in clinical trials for increasing bioavailability. Clin. Cancer Res. 2009, 15 (2), 747.